Home / Markets / Industries / Health Care
Wednesday, November 05, 2008
Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
Comtex
LARGO, Fla., Nov 05, 2008 /PRNewswire-FirstCall via COMTEX/ ----Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of the all new C-VUE(R) Advanced(TM) Custom Toric. The C-VUE Advanced Custom Toric will be sold directly to independent eye care professionals and features a revolutionary trial program, an advanced hydration material and exceptional deliverability (typically ships within in 2 to 3 days).
C-VUE Advanced Custom Toric is available in new convenient blister packaging with hioxifilcon D, a material which offers advanced hydration properties that allow it to retain 97% of its moisture resulting in all day comfort. The new product offering and hassle free trial/no returns necessary program will provide independent practitioners with an additional specialty C-VUE contact lens option that contributes to patient retention and practice profitability.
C-VUE Advanced Custom Toric is an easy to fit specialty toric contact lens, designed in an extremely wide range of customizable parameters with exceptional deliverability. The lens offers made to order base curves, diameters, powers and cylinders combined with axis in one degree steps.
"The launch of the C-VUE Advanced Custom Toric continues our tradition of providing outstanding specialty lens technology exclusively to licensed optical professionals," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "With our revolutionary Free Trial Program for custom lenses, we eliminate the time and expense of returning lenses, thereby increasing profitability to the Independent Eye Care Professional as well," concluded Mr. Pecora.
About Unilens Vision Inc. -- "The Independent Eye Care Professionals Contact Lens Company"
Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-VUE(R) brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com . The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI".
The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For more information, please contact: Kelly McKnight at (727) 544-2531
SOURCE Unilens Vision Inc.
http://www.unilens.com
Copyright (C) 2008 PR Newswire. All rights reserved
Fox Business Video
-
-
Helping Veterans Land Jobs
-
Jul 2, 2009
Baird on Helping Soldiers
-
-
-
President's Plans Working
-
Jul 2, 2009
Goodstein on Stimulus Success
-
-
-
Jackson Lives On
-
Jul 2, 2009
Beck on Future of Jackson
-
-
-
$20 Dollars a Gallon
-
Jul 2, 2009
Paying More to Save Economy
-
-
-
Looking for the Road to Recovery
-
Jul 2, 2009
Morris on Unemployment
-
FOX Translator
No data currently available.
No data currently available.
Some mutual funds want you to pay for the privilege of them (or your investment adviser) taking your money to invest. It's called a load, and it works like a cover charge to get into a nightclub. Luckily, there are such things as no-load funds. As the name implies, shares of these funds are sold without a fee paid to a broker or investment advisor.
The entire amount you invest in no-load funds goes to work for your returns. On the other hand, with load funds, right off the bat you're charged commission (not to mention other fees incurred over the life of the investment). Let's say, for example, you invest $25,000 into a load fund that charges a 5% commission. This costs you $1,250 off the top, bringing your actual investment down to only $23,750.
The often-cited horse race analogy argues against investing in load funds. Here's the logic behind it: Would you place a bet on a horse that had to start a race 200 yards behind the others? Well, maybe you would if you got a tip from a sketchy, trench coat-clad man in a dark alley. However, under most circumstances, it's not smart to put your money on that handicapped horse.
But some argue that at times that man in the trench coat (aka your broker) knows more about the horses than you do, and has a better shot at picking a winner. Also, sometimes these fees are unavoidable because some funds are available only through investment advisers.
Cost-benefit analysis can help determine when a load fund is worth it (in other words, when it will score you a load) and when it is better to "do it yourself" and avoid the fees. Load-fund fees range depending on share class and can cover a variety of costs, such as paper work and fund management.
